Trial Profile
Intervention Study of Istradefylline for the Treatment of Gait Disorders in Patients with Parkinson's Disease.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Sep 2019
Price :
$35
*
At a glance
- Drugs Istradefylline (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- 01 Aug 2019 Results assessing the efficacy and safety of istradefylline in improving gait disorders with freezing of gait questionnaire in patients with Parkinson's disease published in the Expert Opinion on Pharmacotherapy
- 22 Aug 2018 Status changed from active, no longer recruiting to completed.
- 13 Apr 2018 Status changed from not yet recruiting to active, no longer recruiting.